ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670961 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670961; 2) Community: the network communities that were significantly associated with the response to NSC 670961; 3) Molecule: the relationships between components within communities and NSC 670961; 4) MDR: the compounds that were significantly associated with the NSC 670961.

NSC Compound Enrichment Correlation
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0102962192514438 0.41210076
NSC 180973 Tamoxifen citrate 0.0102962192514438 0.33709662
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0102962192514438 0.45559849
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0102962192514438 0.51294284
NSC 220334 Replaced CAS registry number(s): 66835-31-2 0.0102962192514438 0.46541854
NSC 279503 ISOBRUCEIN A 0.0102962192514438 0.27812912
NSC 32924 Null 0.0102962192514438 0.36070044
NSC 625543 ANTINEOPLASTIC-625543 0.0102962192514438 0.74010584
NSC 630602 1-Piperidinecarboxylic acid, 4-oxo-3,5-bis(phenyl- methylene)-, ethyl ester 0.0102962192514438 0.53725371
NSC 634037 4-amino-3-bromo-1-(.beta.-D-ribofuranosyl)pyrrolo[2,3-d] pyridazine 0.0102962192514438 0.50825097
Total:136  Current:49    [First] [Prev] [Next] [Last]